Data DEBUG
Request:
https://api.data.payoff.ch/v2/strproducts/CH1557034621 Response:
{
"meta": {
"id": 36860999,
"categoryId": 12,
"subCategoryId": 1230,
"ibtTypeCode": 100065,
"hasMultipleUnderlyings": true,
"numUnderlyings": 2,
"issuerRef": "UBS",
"hasExtendedTradingHours": false,
"denomination": "1000.00000",
"productNameFull": "15.00% p.a CHF Kick-In GOAL With Early Redemption Feature on Worst of Eli Lilly \/ Novo Nordisk",
"guarantorRef": null
},
"basic": {
"isin": "CH1557034621",
"wkn": null,
"valor": "155703462",
"symbol": "LCHGDU",
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"descriptionTemplate": "template-1230",
"termsheetUrlDe": "\/termsheets\/CH1557034621_de_20260514_002516.pdf",
"termsheetUrlEn": "\/termsheets\/CH1557034621_en_20260514_003023.pdf"
},
"highlights": {
"barrierRate": "60%",
"sidewardYieldMaturity": "11.87%",
"tradingCurrencyCode": "CHF"
},
"static": {
"categoryName": "Renditeoptimierung",
"subCategoryName": "Barrier Reverse Convertible",
"issuerName": "UBS",
"issuerRatings": "Aa2 \/ A+ \/ A+",
"tradingCurrencyCode": "CHF",
"underlying": "Eli Lilly and Co \/ Novo Nordisk A\/S",
"tradingExchangeName": "SIX Structured Products",
"ratio": "1",
"isCollateralised": "Nein",
"issuePrice": "1'000.00",
"firstTradingDate": "13.05.2026",
"lastTradingDate": "04.05.2027",
"redemptionDate": "13.05.2027",
"paymentType": "bar",
"mgmtFeePa": null,
"isCallable": "Nein",
"isAutoCallable": "Ja",
"optionStyle": "amerikanisch",
"couponRate": "15%",
"strikeRate": "100%",
"barrierRate": "60%",
"isQuanto": "Ja"
},
"market": {
"tradingExchangeName": "SIX Structured Products",
"tradingCurrencyCode": "CHF",
"bid": "102.80%",
"bidSize": "0",
"ask": "103.80%",
"askSize": "0",
"last": "102.80%",
"change": "+0.10",
"performanceWeek": "1.68%",
"performanceYtd": null,
"lastDateTime": "24.06.2026 22:10:00"
},
"chart": [
{
"ttsId": "tts-820450",
"name": "Eli Lilly and Co"
},
{
"ttsId": "tts-209092551",
"name": "Novo Nordisk A\/S"
}
],
"keyfigures": {
"daysToMaturity": "313",
"distToBarrierRate": "43.57%",
"barrierHitProbMaturity": "0.22%",
"barrierHitProb10days": "0%",
"maxReturnMaturity": "11.87%",
"sidewardYieldMaturity": "11.87%",
"outperformanceLevel": null
},
"underlyings": [
{
"isin": "US5324571083",
"valor": "947556",
"name": "Eli Lilly and Co",
"symbol": "LLY",
"tradingExchangeName": "SIX Structured Products",
"tradingCurrencyCode": "USD",
"strikeLevel": "987.05",
"bid": "1'111.00",
"bidSize": "80",
"ask": "1'114.00",
"askSize": "40",
"last": "1'117.26",
"change": null,
"distToBarrier": "518.77",
"distToBarrierRate": "46.69%",
"lastDateTime": "24.06.2026 22:01:44"
},
{
"isin": "DK0062498333",
"valor": "129508879",
"name": "Novo Nordisk A\/S",
"symbol": "NOVOB",
"tradingExchangeName": "SIX Structured Products",
"tradingCurrencyCode": "DKK",
"strikeLevel": "293.00",
"bid": "311.55",
"bidSize": null,
"ask": "311.55",
"askSize": null,
"last": "310.30",
"change": null,
"distToBarrier": "135.75",
"distToBarrierRate": "43.57%",
"lastDateTime": "24.06.2026 17:00:45"
}
],
"similars": [
{
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"isin": "CH1502675635",
"symbol": "LBJKDU",
"categoryName": "Renditeoptimierung",
"issuerName": "UBS",
"isAd": false
},
{
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"isin": "CH1489708797",
"symbol": "LBDPDU",
"categoryName": "Renditeoptimierung",
"issuerName": "UBS",
"isAd": false
},
{
"name": "Barrier Reverse Convertible auf Eli Lilly and Co \/ Novo Nordisk A\/S",
"isin": "CH1453399268",
"symbol": "ADNISQ",
"categoryName": "Renditeoptimierung",
"issuerName": "Swissquote",
"isAd": false
}
],
"events": [
]
}
LCHGDU
Barrier Reverse Convertible auf Eli Lilly and Co / Novo Nordisk A/S
Das von UBS emittierte Barrier Reverse Convertible eignet sich für chancenorientierte Investoren, welche kurzfristig eine Seitwärtsbewegung oder leicht positive Wertentwicklung der jeweiligen Basiswerte erwarten.
Stammdaten
- KategorieRenditeoptimierung
- TypBarrier Reverse Convertible
- EmittentUBS
- Ratings (Moody's/S&P/Fitch)Aa2 / A+ / A+
- HandelswährungCHF
- BasiswertEli Lilly and Co / Novo Nordisk A/S
- HandelsplatzSIX Structured Products
- Ratio1
- PfandbesichertNein
- Ausgabepreis1'000.00
- Erster Handelstag13.05.2026
- Letzter Handel04.05.2027
- Rückzahlungsdatum13.05.2027
- Auszahlungsartbar
- CallableNein
- AutocallableJa
- Optionsstilamerikanisch
- Coupon15%
- Strike-Rate100%
- Barriere60%
- QuantoJa
Marktdaten
- BörsenplatzSIX Structured Products
- HandelswährungCHF
- Geldkurs102.80%
- Geld Volumen0
- Briefkurs103.80%
- Brief Volumen0
- Letzter Kurs102.80%
- Veränderung+0.10
- Performance (1 Woche)1.68%
- Kurswerte vom24.06.2026 22:10:00
Kennzahlen
- Tage bis Verfall313
- Min. Abstand zur Barriere43.57%
- Barrier Hit Prob (Verfall)0.22%
- Barrier Hit Prob (10 Tage)0%
- Maximalrendite (Verfall)11.87%
- Seitwärtsrendite (Verfall)11.87%
Chart
Basiswert: Eli Lilly and Co
- Eli Lilly and Co
- ISINUS5324571083
- Valor947556
- BasiswertEli Lilly and Co
- SymbolLLY
- BörsenplatzSIX Structured Products
- HandelwährungUSD
- Strike-Level987.05
- Geldkurs1'111.00
- Geld Volumen80
- Briefkurs1'114.00
- Brief Volumen40
- Letzter Kurs1'117.26
- Abstand zu Barrier518.77
- Distanz zur Barriere46.69%
- Kurswerte vom24.06.2026 22:01:44
Basiswert: Novo Nordisk A/S
- Novo Nordisk A/S
- ISINDK0062498333
- Valor129508879
- BasiswertNovo Nordisk A/S
- SymbolNOVOB
- BörsenplatzSIX Structured Products
- HandelwährungDKK
- Strike-Level293.00
- Geldkurs311.55
- Briefkurs311.55
- Letzter Kurs310.30
- Abstand zu Barrier135.75
- Distanz zur Barriere43.57%
- Kurswerte vom24.06.2026 17:00:45